+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Non-stimulant medications in the treatment of ADHD

Non-stimulant medications in the treatment of ADHD

European Child and Adolescent Psychiatry 13 Suppl 1: I102-I116

Stimulants are the first-line medication in the psychopharmacological treatment of attention-deficit hyperactivity disorder (ADHD). However, 10 to 30% of all children and adults with ADHD either do not respond to or do not tolerate treatment with stimulants. To describe alternative treatment approaches with various non-stimulant agents, especially atomoxetine. General review of empirically based literature concerning efficacy and safety of the substances. A large and still increasing body of data supports the usefulness of atomoxetine, a once daily dosing, and new selective noradrenalin reuptake inhibitor, with few side effects. Atomoxetine has been licensed in the US for use in ADHD across the lifespan, and is currently under consideration in Europe. Other non-stimulant substances, such as tricyclic antidepressants (TCAs) and alpha-2-adrenergic agonists, which are used to treat ADHD, are also reviewed. TCAs have been well studied and shown to be efficacious in the treatment of ADHD, but are limited by side effects. The number of studies documenting the efficacy of alpha-2-adrenergic agonists is still limited. Some experimental studies support a potential role of cholinergic drugs such as acetylcholinesterase inhibitors (tacrine, donepezil) as well as novel nicotinic analogues (ABT-418). Non-stimulant agents have been shown to be effective in treatment of ADHD. Especially, atomoxetine seems promising and newline drugs are in development.

(PDF emailed within 0-6 h: $19.90)

Accession: 049704401

Download citation: RISBibTeXText

PMID: 15322961

DOI: 10.1007/s00787-004-1010-x

Related references

Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine. Journal of the American Academy of Child and Adolescent Psychiatry 45(10): 1147-1150, 2006

Stimulant medications for attention-deficit/hyperactivity disorder (ADHD) improve memory of emotional stimuli in ADHD-diagnosed college students. Pharmacology, Biochemistry, and Behavior 105: 58-62, 2013

Nonmedical use of prescription ADHD stimulant medications among adults in a substance abuse treatment population: early findings from the NAVIPPRO surveillance system. Journal of Attention Disorders 19(4): 275-283, 2015

The effects of stimulant medications for ADHD. National Bureau of Economic Research Bulletin on Aging and Health: 1-2, 2014

Cardiovascular Effects of Stimulant Medications Taken for ADHD. Aap Grand Rounds 15(1): 4-5, 2006

The use of stimulant medications for non-core aspects of ADHD and in other disorders. Neuropharmacology 87: 161-172, 2015

The Effects of Stimulant Medications on the Art Products of ADHD Children. Art Therapy 9(1): 36-41, 1992

Stimulant medications: a trade-off? The lived experience of adolescents with ADHD. Journal for Specialists in Pediatric Nursing 11(4): 214-226, 2006

Stimulant Medications and Sleep for Youth With ADHD: A Meta-analysis. Pediatrics 136(6): 1144-1153, 2016

Using nonpharmacological treatments in conjunction with stimulant medications for children with Adhd*1. Journal of Pediatric Health Care 18(5): 255-259, 2004

Do stimulant medications improve educational and behavioral outcomes for children with ADHD?. Journal of Health Economics 37: 58-69, 2016

Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children. Minnesota Medicine 83(6): 45-46, 2000

Duration of effect of oral long-acting stimulant medications for ADHD throughout the day. Current Medical Research and Opinion 26(8): 1809-1825, 2010

Long-term safety of stimulant medications used to treat children with ADHD. Pediatric Annals 37(1): 37-45, 2008

Interventions in ADHD: A comparative review of stimulant medications and behavioral therapies. Asian Journal of Psychiatry 25: 131-135, 2017